Key Highlights

● Alexandria last closed at $45.68 on 8 October 2026, and the $52.31 consensus target implies upside of about 14.5 per cent on paper.

● The consensus draws on 16 analysts, with targets from $40 to $60.

● Ratings split into two Buy, ten Hold and four Sell, a Reduce consensus in market data.

● BNP Paribas Exane cut its target to $40 from $48 on 29 September, and JPMorgan downgraded to Underweight with a $56 target on 24 September.

Alexandria Real Estate Equities, Inc. (NYSE:ARE) is a real estate investment trust focused on life-science and technology campuses. The last close in the data was $45.68 on 8 October 2026, with the consensus analyst target about 14.5 per cent higher.

What Is the Latest Analyst Price Target?

The consensus (mean) price target is $52.31, based on 16 analysts with ratings in the previous twelve months. The data is dated 8 October 2026. The range runs from a low of $40.00 to a high of $60.00. Compared with the $45.68 price, the consensus target suggests potential upside of about 14.5 per cent.

What Are Wall Street Analysts Saying?

The rating split is 2 Buy, 10 Hold, 4 Sell (market data consensus: Reduce). In late September 2026 BNP Paribas Exane (Nate Crossett) cut its target to $40 from $48 with an Underperform rating (29 September), BMO Capital Markets (John Kim) lowered to $48 from $52 (28 September), Jefferies trimmed to $46 from $47 (24 September), and JPMorgan (Anthony Paolone) downgraded to Underweight with a $56 target (24 September). On the more positive side, Evercore (James Kammert) reiterated Outperform with a $59 target on 21 September and Goldman Sachs (Julien Blouin) raised to $59 from $54 on 18 September. Mizuho held a $60 target after a July cut from $70.

What Could Help the Stock Reach the Price Target?

For the shares to move towards the consensus target, analysts would be looking for stabilising demand for laboratory space, a recovery in sentiment towards life-science real estate and progress on balance-sheet management. Evercore and Goldman Sachs both carry $59 targets, and the high target is $60.

What Could Prevent the Stock Reaching the Target?

The main risks include the cluster of late-September downgrades and target cuts, a consensus rating of Reduce with four Sell ratings, and the sensitivity of real estate investment trusts to interest rates and tenant demand. The lowest target, $40 from BNP Paribas Exane, sits below the latest close. Share prices can also be affected by broader market conditions, interest rates and company-specific news that analysts did not anticipate.

What Should Investors Watch Next?

The next quarterly results are the most obvious catalyst, as they usually prompt analysts to revise ratings and targets. Other things to watch include further broker target changes, management guidance and sector-wide data.

Alexandria's Late-September Downgrades Weigh on a Reduce Consensus

Alexandria last closed at $45.68 on 8 October 2026, and the $52.31 consensus target implies about 14.5 per cent upside on paper, with targets ranging from $40.00 to $60.00. The mix behind it is cautious: four Sell ratings and a Reduce consensus, plus a cluster of late-September cuts from BNP Paribas Exane, BMO Capital Markets and Jefferies and JPMorgan's downgrade to Underweight, against Outperform views from Evercore and a raise to $59 from Goldman Sachs. The lowest target, $40 from BNP Paribas Exane, sits below the latest close.